Superworth

Eli Lilly and EV/EBIT LLY

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2010.

Today, Oct 23, 2026
35.7×
10-year median
35.7×
Against its 10-year history
50th
percentile: 0 is its lowest day, 100 its highest
10-year range
19.2× to 104×
Peer median
21.9×

Eli Lilly and's EV/EBIT is 35.7× as of Oct 23, 2026.

That is below its ten-year median of 35.7×, close to the middle of its last ten years.

Over that time it ranged from 19.2× in May 2018 to 104× in Jul 2024.

The median for 7 large drugmakers of a similar size is 21.9×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far35.7×30.8×45.9×
202545.8×32.0×68.5×
202461.3×58.6×104×
202375.6×39.4×77.8×
202243.7×33.3×44.7×
202141.4×30.9×44.6×
202031.3×23.7×31.8×
201928.5×24.3×37.1×
201831.3×19.2×36.1×
201731.3×27.0×33.8×
201628.2×23.9×31.3×
201528.0×22.9×33.5×
201423.1×9.5×23.7×
20139.5×8.6×11.8×
20129.9×7.8×11.9×
20118.3×5.9×8.3×
20106.5×6.3×7.1×

Against its peers

Companies in Drug Manufacturers - General nearest Eli Lilly and's size, closest first, today.

CompanyEV/EBIT
LLYEli Lilly and35.7×
JNJJohnson & Johnsonn/m
ABBVAbbVie27.2×
MRKMerck20.4×
AMGNAmgen24.6×
GILDGilead Sciences23.4×
PFEPfizer14.5×
BMYBristol-Myers Squibb12.4×
Peer median21.9×

Where Eli Lilly and ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Eli Lilly and

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.